These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies. Sniadack DH; Schwartz B; Lipman H; Bogaerts J; Butler JC; Dagan R; Echaniz-Aviles G; Lloyd-Evans N; Fenoll A; Girgis NI Pediatr Infect Dis J; 1995 Jun; 14(6):503-10. PubMed ID: 7667055 [TBL] [Abstract][Full Text] [Related]
23. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. Robbins JB; Austrian R; Lee CJ; Rastogi SC; Schiffman G; Henrichsen J; Mäkelä PH; Broome CV; Facklam RR; Tiesjema RH J Infect Dis; 1983 Dec; 148(6):1136-59. PubMed ID: 6361173 [No Abstract] [Full Text] [Related]
24. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta. Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217 [TBL] [Abstract][Full Text] [Related]
25. Pneumococcal vaccination for older adults: the first 20 years. Fedson DS Drugs Aging; 1999; 15 Suppl 1():21-30. PubMed ID: 10690792 [TBL] [Abstract][Full Text] [Related]
26. Clinical practice and public policy for influenza and pneumococcal vaccination of the elderly. Fedson DS Clin Geriatr Med; 1992 Feb; 8(1):183-99. PubMed ID: 1576575 [TBL] [Abstract][Full Text] [Related]
27. [Vaccination against Streptococcus pneumoniae in solid organ transplant recipients]. Fiorante S; López-Medrano F; Ruiz-Contreras J; Aguado JM Enferm Infecc Microbiol Clin; 2009 Dec; 27(10):589-92. PubMed ID: 19361892 [TBL] [Abstract][Full Text] [Related]
29. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23). American Academy of Pediatrics Committee on Infectious Diseases Pediatrics; 2010 Jul; 126(1):186-90. PubMed ID: 20498180 [TBL] [Abstract][Full Text] [Related]
30. The utilization of pneumococcal polysaccharide vaccine among elderly Medicare beneficiaries, 1985 through 1988. McBean AM; Babish JD; Prihoda R Arch Intern Med; 1991 Oct; 151(10):2009-16. PubMed ID: 1929689 [TBL] [Abstract][Full Text] [Related]
31. Time for changes in pneumococcal vaccination of adults? Overman MC J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S19-22. PubMed ID: 22086890 [TBL] [Abstract][Full Text] [Related]
32. Immunologic non-inferiority and safety of the investigational pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) 4-dose vial presentation compared to the licensed PHiD-CV 1-dose vial presentation in infants: A phase III randomized study. Zaman K; Zaman SF; Zaman F; Aziz A; Faisal SB; Traskine M; Habib MA; Ruiz-Guiñazú J; Borys D Vaccine; 2018 Jan; 36(5):698-706. PubMed ID: 29277353 [TBL] [Abstract][Full Text] [Related]
33. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). Nuorti JP; Whitney CG; MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868 [TBL] [Abstract][Full Text] [Related]
34. [Pneumococcal infections: Appraisal and perspectives in terms of adult vaccination]. Baratali L; Lang PO Presse Med; 2015 Nov; 44(11):1155-61. PubMed ID: 26363530 [TBL] [Abstract][Full Text] [Related]
35. Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine among Mexican children. Espinosa-Padilla SE; Murata C; Estrada-Parra S; Santos-Argumedo L; Mascareñas C; Franco-Paredes C; Espinosa-Rosales FJ Arch Med Res; 2012 Jul; 43(5):402-5. PubMed ID: 22868187 [TBL] [Abstract][Full Text] [Related]
36. The cost effectiveness of pneumococcal vaccination strategies. Gable CB; Botteman M; Savage G; Joy K Pharmacoeconomics; 1997 Aug; 12(2 Pt 1):161-74. PubMed ID: 10169668 [TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of the pneumococcal vaccine in the United States Navy and Marine Corps. Vold Pepper P; Owens DK Clin Infect Dis; 2000 Jan; 30(1):157-64. PubMed ID: 10619745 [TBL] [Abstract][Full Text] [Related]